The Food and Drug Administration has accepted an application by Philip Morris International for modified risk approval from the FDA for its iQOS tobacco heating product, according to Altria Group.

Altria, which owns Philip Morris USA, said FDA has begun the science review required for a Modified Risk Tobacco Product (MRTP) application and expects to solicit public comment. PM USA has an exclusive agreement with PMI to sell iQOS in the United States.